Filtros de búsqueda

Lista de obras de Isabelle Ray-Coquard

17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1

artículo científico publicado en 2015

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer

artículo científico publicado en 2009

A comparison of Australian and French families affected by sarcoma: perceptions of genetics and incidental findings

article

A controlled "before-after" study: impact of a clinical guidelines programme and regional cancer network organization on medical practice

artículo científico publicado en 2002

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours

artículo científico publicado en 2013

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

artículo científico publicado en 2020

A phase 2 trial of whole-brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

artículo científico publicado en 2008

A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

artículo científico publicado en 2009

A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors

artículo científico publicado en 2010

A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients

artículo científico publicado en 2002

A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors

artículo científico publicado en 2014

A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study)

artículo científico publicado en 2019

A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens

artículo científico publicado en 2008

A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma

artículo científico publicado en 2014

A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

artículo científico publicado en 2013

A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.

artículo científico publicado en 2013

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

artículo científico publicado en 2010

A prospective, observational study describing the haematological response in patients undergoing chemotherapy treated by tri-weekly darbepoetin alfa for anaemia

artículo científico publicado en 2010

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group ⬇️

artículo científico publicado el 8 de noviembre de 2012

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (

artículo científico publicado en 2020

A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma.

artículo científico publicado en 2013

A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin alpha: a prospective randomized controlled trial of the ELYPSE study group

artículo científico publicado en 2009

A role for maintenance therapy in managing sarcoma

artículo científico

Abstract 2267: Long term prognostic impact of CD4 and CD8 lymphopenia and rapid recovery in a cohort of 220 patients with a 10 years follow-up

Abstract 2574: Interleukin-7 (CYT107) treatment in lymphopenic 1stline metastatic breast carcinoma patients treated with chemotherapy regimen (Capecitabine) favors the restoration of T-cell subsets number

Abstract 5578: IGF-1R nuclear staining in tumor cells identifies sarcoma patients with a prolonged progression free survival after IGF-1R monoclonal antibody therapy

Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme

artículo científico publicado en 2019

Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET)

artículo científico publicado en 2013

Adjuvant therapy with imatinib in gastrointestinal stromal tumors (GISTs)-review and perspectives

artículo científico publicado en 2019

Advanced chondrosarcomas: role of chemotherapy and survival.

artículo científico publicado en 2013

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial

artículo científico publicado en 2019

An Increasing Role for Trabectedin in Gynecological Cancers: Efficacy in Uterine Sarcomas ⬇️

artículo científico publicado el 1 de mayo de 2011

Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study.

artículo científico publicado en 2018

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy in sarcoma (OUTC's)

artículo científico publicado en 2017

Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.

artículo científico publicado en 2017

Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety

artículo científico publicado en 2019

Are antiangiogenic antibodies universal for solid tumor?

artículo científico publicado en 2007

Assessing the performance of indicators during their life cycle: the mixed QUID method

artículo científico publicado en 2019

Author Correction: Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study

artículo científico publicado en 2018

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas

artículo científico publicado en 2013

BCG therapy-related death and previous pelvic radiation

scientific article published on 01 July 2001

Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy

artículo científico publicado en 2003

Being treated in higher volume hospitals leads to longer progression-free survival for epithelial ovarian carcinoma patients in the Rhone-Alpes region of France

artículo científico publicado en 2018

Bevacizumab and paclitaxel for breast cancer patients with central nervous system metastases: a case series.

artículo científico publicado en 2009

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial

artículo científico publicado en 2014

Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.

artículo científico publicado en 2011

Biology of ovarian cancer and trabectedin mechanism of action

artículo científico publicado en 2013

Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)

artículo científico publicado en 2018

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmaco

artículo científico publicado en 2013

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 2006

CA-125 ELIMination rate constant K (KELIM) Is A Marker Of Chemosensitivity In Patients With Ovarian Cancer: Results from the Phase II CHIVA trial

scientific article published on 24 March 2020

CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumour in France: Results From the Network RREPS

article

CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.

artículo científico publicado en 2004

CD4 lymphopenia to identify end-of-life metastatic cancer patients

artículo científico publicado en 2012

Cabozantinib as an emerging treatment for sarcoma

artículo científico publicado en 2020

Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial

artículo científico publicado en 2020

Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial ⬇️

artículo científico publicado el 17 de diciembre de 2012

Cancer screening and follow-up in general practice: A French nationwide cross-sectional study

scientific article published on 01 December 2020

Cancers de l’ovaire BRCA muté : consultation d’oncogénétique et prescription des inhibiteurs de PARP.

artículo científico publicado en 2017

Cervix cancer and corpus cancer of the uterus

artículo científico publicado el 1 de diciembre de 2011

Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer

scientific article published on 12 September 2020

Chemotherapy for metastatic breast cancer. Comparison of clinical practice and cost of drugs in two cohorts of patients: 1994–1998 and 2003–2006

scientific article published on 24 December 2010

Chemotherapy with radiotherapy influences time-to-development of radiation-induced sarcomas: a multicenter study

artículo científico publicado en 2017

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

artículo científico publicado en 2009

Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers

artículo científico publicado en 2019

Clinical management of adolescents and young adults suffering from sarcoma in the French Rhône-Alpes region: A prospective exhaustive cohort with 10 years follow up

scientific article published on 02 April 2020

Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)

artículo científico publicado en 2004

Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?

artículo científico publicado en 2020

Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative ⬇️

artículo científico publicado en 2014

Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions

artículo científico publicado en 2012

Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis

artículo científico publicado en 2019

Combined oral topotecan plus carboplatin in relapsed or advanced cervical cancer: a GINECO phase I-II trial

artículo científico publicado el 1 de marzo de 2012

Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study)

artículo científico publicado en 2020

Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).

artículo científico publicado en 2008

Compliance to regional recommendations for molecular analyses and management of advanced lung cancer patients

scientific article published on 12 June 2019

Concordance between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial

artículo científico publicado en 2020

Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas

artículo científico publicado en 2004

Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.

artículo científico publicado en 2005

Correction to: Beyond the map: evidencing the spatial dimension of health inequalities

scientific article published on 04 January 2021

Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma Group

artículo científico publicado en 2013

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients

artículo científico publicado en 2016

Current role of poly(ADP-ribose) polymerase inhibitors: which poly(ADP-ribose) polymerase inhibitor and when?

artículo científico publicado en 2019

Cutaneous lesions in sporadic angiosarcomas of the breast: a misleading presentation

artículo científico publicado en 2016

Cyclooxygenase 2 and breast cancer. From biological concepts to clinical trials

artículo científico publicado en 2004

Cyclooxygenase 2 and breast cancer. From biological concepts to therapeutic trials

artículo científico publicado en 2004

DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study

artículo científico publicado en 2015

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Data from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial

artículo científico publicado en 2011

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

artículo científico publicado en 2004

Detailed overview on rare malignant ovarian tumors

artículo científico publicado en 2020

Development and validation of a bedside score to predict early death in cancer of unknown primary patients

artículo científico publicado en 2009

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics

article

Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE)

scientific article published on 17 June 2020

Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)

scientific article published on 12 February 2020

Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe study

artículo científico publicado en 2011

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

artículo científico publicado en 2010

Do our current clinical trial designs help to guide clinical practice?

artículo científico

Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis

artículo científico publicado en 2006

Docetaxel and ovarian cancer

artículo científico publicado en 2004

Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT)

artículo científico publicado en 2020

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tiss

artículo científico publicado en 2020

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

artículo científico publicado en 2017

Drug management of prostate cancer: prevalence and consequences of renal insufficiency

artículo científico publicado en 2009

Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?

artículo científico publicado en 2016

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.

artículo científico

ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.

artículo científico publicado en 2018

ERCC5/XPG, ERCC1, and BRCA1 gene status and clinical benefit of trabectedin in patients with soft tissue sarcoma

artículo científico publicado en 2011

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer

scientific article published on 28 September 2020

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

scientific article published on 02 May 2019

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†

artículo científico publicado en 2019

ET-743: a novel agent with activity in soft tissue sarcomas

artículo científico publicado en 2005

ET-743: a novel agent with activity in soft-tissue sarcomas

artículo científico publicado en 2006

ETIOSARC study : environmental aetiology of sarcomas from a French prospective multicentric population-based case-control study-study protocol

artículo científico publicado en 2019

Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study

scientific article published on 01 April 2019

Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial

scientific article published on 08 October 2020

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

artículo científico publicado en 2012

Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution

artículo científico publicado en 2010

Emerging drugs for the treatment of soft tissue sarcomas

artículo científico publicado en 2007

Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: focus on trabectedin

artículo científico

Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region

artículo científico publicado en 2010

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

artículo científico publicado en 2015

Epirubicin and paclitaxel (EPI-TAX regimen) for advanced ovarian cancer after failure of platinum-containing regimens

artículo científico publicado en 2003

Erratum

Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

artículo científico publicado en 2016

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

artículo científico publicado en 2009

European Journal of Cancer's Biennial report on soft tissue and visceral sarcomas or the rapid evolution of treatment concepts in sarcomas

artículo científico publicado en 2016

European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groupsand industry partners - a new Model D for drug and medical device development

artículo científico publicado en 2020

European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery.

artículo científico publicado en 2016

European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

scientific article published on 01 September 2017

Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses

artículo científico publicado en 2003

Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO.

artículo científico publicado en 2013

Expectation about maintenance therapy among the GINECO French ovarian cancer cohort from the European NOGGO/ENGOT-ov22 Expression IV survey

artículo científico publicado en 2018

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

artículo científico publicado en 2017

Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer.

artículo científico publicado en 2010

Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group

artículo científico publicado en 2020

Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelings

artículo científico publicado en 2018

Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer

artículo científico publicado en 2018

Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers

scientific article published on 03 June 2019

Fifteen important questions for oncology to be addressed from 2015

scientific article published on 01 June 2015

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours

artículo científico publicado en 2016

Final Results of ERASME-4: A Randomized Trial of First-Line Docetaxel plus either Capecitabine or Epirubicin for Metastatic Breast Cancer ⬇️

artículo científico publicado el 6 de julio de 2011

Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

artículo científico publicado en 2019

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.

artículo científico publicado en 2016

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN

artículo científico publicado en 2020

First-line PARP inhibitors in ovarian cancer: summary of an <i>ESMO Open - Cancer Horizons</i> round-table discussion

scientific article published on 01 November 2020

First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer.

artículo científico publicado en 2012

Gastro-intestinal stromal tumors: news and comments

artículo científico publicado en 2003

Gastrointestinal stromal tumors (GIST): a rare entity, a tumor model for personalized therapy, and yet ten different molecular subtypes

artículo científico publicado el 1 de mayo de 2012

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group

artículo científico publicado en 2009

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration

artículo científico publicado en 2018

Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol

artículo científico publicado en 2017

Geographical Accessibility of the Referral Networks in France. Intermediate Results from the IGéAS Research Program

article

Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients

artículo científico publicado en 2017

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary.

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian small cell cancers

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas

artículo científico publicado en 2014

Gynecological sarcomas: what's new in 2018, a brief review of published literature

scientific article published on 01 July 2018

Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1).

artículo científico

High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR

artículo científico publicado en 2020

High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis

artículo científico publicado en 2017

High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trial

artículo científico publicado en 2011

High-dose chemotherapy in soft tissue sarcomas of adults

artículo científico publicado en 2001

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults

artículo científico publicado en 2000

High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches

artículo científico publicado en 2014

Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072

artículo científico publicado en 2015

Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer

artículo científico publicado en 2010

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis

artículo científico publicado en 2010

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas

artículo científico publicado en 2001

Imatinib and solid tumours

artículo científico publicado en 2008

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up

artículo científico publicado en 2010

Imatinib mesilate for the treatment of gastrointestinal stromal tumour

scientific article published on May 2008

Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay.

artículo científico publicado en 2015

Immunotherapy and epithelial ovarian cancer: a double-edged sword?

artículo científico publicado en 2017

Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study

scientific article published on 26 November 2019

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial

artículo científico publicado en 2018

Impact of a Clinical Guidelines Program for Breast and Colon Cancer in a French Cancer Center ⬇️

artículo científico publicado el 19 de noviembre de 1997

Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network

artículo científico publicado en 2013

Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line ch

artículo científico publicado en 2016

Impact of clinical practice guidelines on the diagnostic strategy for carcinomas of unknown primary site: a controlled 'before-after' study

artículo científico publicado en 2008

Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study.

artículo científico publicado en 2009

Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first-line setting. Exhaustive analysis from the Rhone-Alpes region

artículo científico publicado en 2020

Improved survival using specialized multidisciplinary board in sarcoma patients

artículo científico publicado en 2017

Improvement in contraceptive coverage and gynecological care of adult women with cystic fibrosis following the implementation of an on-site gynecological consultation

scientific article published on 28 November 2019

Improving treatment results with reference centres for rare cancers: where do we stand?

artículo científico publicado en 2017

Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM)

artículo científico publicado en 2020

Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

artículo científico publicado en 2011

Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions.

artículo científico publicado en 2012

Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region

artículo científico publicado en 2010

Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials

artículo científico publicado en 2020

Incorporation of pazopanib in maintenance therapy of ovarian cancer

artículo científico publicado en 2014

Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial

artículo científico publicado en 2012

Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial

artículo científico publicado en 2005

Initial management of advanced ovarian cancer: What radiological, pathological and surgical information are important for optimal therapeutic strategy?

artículo científico publicado en 2015

Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas

artículo científico publicado en 2012

Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group

artículo científico publicado en 2007

International Journal of Gynecological Cancer. Editorial

artículo científico publicado en 2014

Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial

artículo científico publicado en 2015

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm study.

artículo científico

Is colon cancer management in a comprehensive cancer centre evidence-based?

artículo científico publicado en 1999

Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour?

scientific article published on July 2009

KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome

artículo científico publicado en 2015

Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group

scientific article published on 16 February 2019

Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.

artículo científico publicado en 2017

Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)

scientific article published on 20 May 2020

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

artículo científico publicado en 2013

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

artículo científico publicado en 2015

Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial

artículo científico publicado en 2013

Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site

scientific article published on 01 December 2006

Low-grade serous ovarian cancer: State of the science

scientific article published on 20 January 2020

Low-grade serous ovarian cancer: expert consensus report on the state of the science

scientific article published on 17 August 2023

Lung cancer and renal insufficiency: prevalence and anticancer drug issues.

artículo científico publicado en 2008

Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas

artículo científico publicado en 2009

Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

artículo científico publicado en 2012

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

scientific article published on 28 March 2019

Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma

artículo científico publicado en 2005

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

artículo científico publicado en 2020

Maintenance therapy in the treatment of sarcoma

artículo científico publicado el 1 de octubre de 2011

Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).

artículo científico publicado en 2016

Management of Anemia in Advanced Breast and Lung Cancer Patients in Daily Practice: Results of a French Survey ⬇️

artículo científico publicado el 1 de febrero de 2012

Management of Rare Ovarian Cancer Histologies

scientific article published on 12 August 2019

Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

artículo científico publicado en 2016

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploratio

scientific article published on 30 March 2019

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa

artículo científico publicado en 2019

Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatm

scientific article published on 29 March 2019

Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients

artículo científico publicado en 2010

Management of relapsed ovarian cancer in routine clinical practice: a case study

scientific article published on 01 October 2018

Managing recurrent ovarian cancer in daily clinical practice: case studies and evidence review with a focus on use of trabectedin

scientific article published on 23 December 2020

Mapping the literature: role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma

artículo científico publicado en 2009

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial

artículo científico publicado en 2014

Mechanisms of resistance to endocrine therapies for breast cancer

artículo científico publicado en 2012

Medical practices and cancer care networks: examples in oncology

artículo científico publicado en 2006

Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

artículo científico publicado en 2011

Methotrexate-Etoposide-Ifosfamide Compared with Doxorubicin-Cisplatin-Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18-25 Years

artículo científico publicado en 2019

Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History

scientific article published on 11 September 2020

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

artículo científico publicado en 2023

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2) ⬇️

artículo científico publicado en 2021

Molecular biology of sarcoma and therapeutic choices

artículo científico publicado en 2015

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

scientific article published on 01 May 2019

Monogenic and polygenic determinants of sarcoma risk: an international genetic study

artículos científicos

Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience

artículo científico publicado en 2010

Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Res

artículo científico publicado en 2010

Multidisciplinarity and medical decision, impact for patients with cancer: sociological assessment of two tumour committees' organization

artículo científico publicado en 2012

Multidisciplinary management of advanced ovarian cancer for an optimal therapeutic strategy

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

scientific article published on 01 February 2000

Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database

artículo científico publicado en 2020

Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and CGH-documented case report

artículo científico publicado en 2015

Na(+)-K(+)-ATPase alpha(2)-isoform expression in guinea pig hearts during transition from compensation to decompensation

scientific article published on 01 October 2000

Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network

artículo científico publicado en 2020

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

artículo científico publicado en 2011

Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art

artículo científico publicado en 2020

Networking for ovarian rare tumors: a significant breakthrough improving disease management.

artículo científico publicado en 2017

New clinical research strategies for rare gynecologic malignancies

artículo científico

New developments in treatment of ovarian carcinoma: focus on trabectedin

artículo científico publicado en 2010

News of the year 2005 in sarcomas

artículo científico publicado en 2006

Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2018

Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial

scientific article published on 14 November 2018

Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib

artículo científico publicado en 2008

Novel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challenges

artículo científico

Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes).

artículo científico publicado en 2015

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

scientific article published on 01 December 2019

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

artículo científico publicado en 2017

Open-label feasibility study of pazopanib, carboplatin, and paclitaxel in women with newly diagnosed, untreated, gynaecologic tumours: a phase I/II trial of the AGO study group ⬇️

artículo científico publicado el 12 de enero de 2012

Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase

artículo científico publicado en 2016

Options for treating different soft tissue sarcoma subtypes

artículo científico publicado en 2018

Oral ridaforolimus plus trastuzumab for patients with HER2+ trastuzumab-refractory metastatic breast cancer

artículo científico publicado en 2014

Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE.

artículo científico publicado en 2012

Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study

artículo científico publicado en 2018

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience

artículo científico publicado en 2013

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.

artículo científico publicado en 2016

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?

artículo científico publicado en 2020

PAIR-gynaecology: multi/interdisciplinary for gynecologic cancer research. Problems needed to be resolved

artículo científico publicado en 2012

PI3 kinase inhibitors in the clinic: an update

artículo científico

PRM143 Cluster Analysis and Principal Component Analysis to Assess the Variability of Data in Cost Evaluations: Methods and Applications in Oncology

article by L. Perrier et al published November 2012 in Value in Health

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial

artículo científico publicado en 2015

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium

scientific article published on 10 September 2019

Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study

artículo científico publicado en 2017

Pazopanib for the treatment of soft-tissue sarcoma ⬇️

artículo científico publicado el 26 de octubre de 2012

Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

artículo científico publicado en 2019

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

artículo científico publicado en 2016

Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC stu

artículo científico publicado en 2009

Peritoneal carcinomatosis and hepatic infiltration related to the dissemination of a micropapillary cell carcinoma of the bladder

artículo científico publicado el 1 de agosto de 2003

Persistence of medical change at implementation of clinical guidelines on medical practice: a controlled study in a cancer network

artículo científico publicado en 2005

Phase I combination study of trabectedin and doxorubicin in patients with soft-tissue sarcoma

artículo científico publicado en 2008

Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies

artículo científico publicado en 2017

Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes

artículo científico publicado en 2009

Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer

artículo científico publicado en 2017

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial

artículo científico publicado en 2005

Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma ⬇️

artículo científico publicado el 5 de julio de 2012

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).

artículo científico publicado en 2010

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.

artículo científico publicado en 2017

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

artículo científico publicado en 2008

Phyllodes tumor of the breast.

artículo científico publicado en 2007

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

artículo científico publicado en 2012

Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials

artículo científico publicado en 2010

Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.

artículo científico publicado en 2013

Pregnancy in Women with Metastatic Sarcomas

scientific article published on 19 September 2020

Presentation and outcome of frequent and rare sarcoma histologic subtypes: A study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers.

artículo científico publicado en 2017

Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues

artículo científico publicado en 2008

Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

artículo científico publicado en 2013

Primary ovarian borderline tumor in the inguinal lymph node.

artículo científico publicado en 2013

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial

scientific article published on 11 October 2018

Prognostic gene expression signature for high-grade serous ovarian cancer

artículo científico publicado en 2020

Prognostic impact of the time interval between surgery and chemotherapy in advanced ovarian cancer: analysis of prospective randomised phase III trials

artículo científico publicado en 2012

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

artículo científico publicado en 2003

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer

artículo científico publicado en 2011

Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group

scientific article published on 29 September 2020

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group

artículo científico publicado en 2007

Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).

artículo científico publicado en 2013

Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

artículo científico publicado en 2011

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study

scientific article published on 01 March 2019

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study ⬇️

artículo científico publicado el 7 de mayo de 2012

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.

artículo científico

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecologi

artículo científico publicado en 2013

Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors

scientific article published on 08 September 2020

Rare Gynecologic Tumors: Coming of Age

scientific article published on 01 April 2020

Rare ovarian tumors: an update on diagnosis and treatment

artículo científico publicado en 2020

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting

artículo científico publicado en 2017

Real-World Delivery of Rucaparib to Patients with Ovarian Cancer: Recommendations Based on an Integrated Safety Analysis of ARIEL2 and Study 10

scientific article published on 01 October 2019

Recent advances in understanding and managing leiomyosarcomas

artículo científico publicado en 2015

Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients

artículo científico publicado en 2012

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

artículo científico publicado en 2009

Recommandations pour la prise en charge des tumeurs stromales gastro-intestinales

artículo científico publicado en 2006

Recommendations for the management of GIST patients

artículo científico publicado en 2005

Reduced risk of second primary cancer in patients treated with immune checkpoint inhibitors for a first cancer

scientific article published on 08 September 2020

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

artículo científico publicado en 2009

Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting

artículo científico publicado en 2016

Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study

artículo científico publicado en 2008

Renovascular safety of bevacizumab in breast cancer patients. The prognostic value of hypertension and proteinuria

artículo científico publicado en 2015

Reply to B. Biswas and D. Dabkara.

artículo científico publicado en 2015

Reply to J.-H. Choi et al ⬇️

artículo científico publicado el 1 de febrero de 2013

Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study

scientific article published on 19 July 2019

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy

artículo científico publicado en 2013

Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group

artículo científico publicado en 2014

Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

artículo científico publicado en 2018

Risk Model Predictive of Severe Anemia Requiring RBC Transfusion After Chemotherapy in Pediatric Solid Tumor Patients

article

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

scientific article published on 08 October 2020

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group

artículo científico publicado en 1999

Risk of death of patients with cancer presenting with severe symptoms of infection, with or without documented COVID-19: In reply to van Dam et al

artículo científico publicado en 2020

Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas

artículo científico publicado en 2019

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial

artículo científico publicado en 2009

Routine Clinical Practice for Patients With Recurrent Ovarian Carcinoma: Results From the TROCADERO Study

artículo científico publicado en 2016

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

artículo científico publicado en 2016

Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial

artículo científico publicado en 2016

Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study

artículo científico publicado en 2016

Sarcoma in 2016: Evolving biological understanding and treatment of sarcomas

artículo científico publicado en 2016

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

artículo científico publicado en 2012

Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years

scientific article published on 15 April 2019

Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer

artículo científico

Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey)

article

Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines

scientific article published on 10 March 2020

Soft Tissue and Uterine Leiomyosarcoma

artículo científico publicado en 2017

Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?

artículo científico publicado en 2011

Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2012

Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO).

artículo científico publicado en 2013

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2015

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Supplementary Data 1 from Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

Surgery in reference centers improves survival of sarcoma patients: a nationwide study

scientific article published on 01 July 2019

Surgery in reference centers improves survival of sarcoma patients: a nationwide study

scientific article published on 01 August 2019

Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network

artículo científico publicado en 2022

Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study

artículo científico publicado en 2020

Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: A nationwide prospective cohort from the French Sarcoma Group

artículo científico publicado en 2017

Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)

artículo científico publicado en 2017

Targeted therapies: pazopanib for soft-tissue sarcoma: a PALETTE of data emerges

artículo científico publicado en 2012

Targeted therapy of sarcomas

artículo científico publicado en 2008

Targeted treatment of cancers with imatinib mesylate (STI571, Gleevec): results of Asco 2002

artículo científico publicado en 2002

Targeted treatment of rare connective tissue tumors and sarcomas

artículo científico publicado en 2010

Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomas.

artículo científico publicado en 2004

Territorial inequalities in management and conformity to clinical guidelines for sarcoma patients: an exhaustive population-based cohort analysis in the Rhône-Alpes region

artículo científico publicado en 2013

The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study

artículo científico publicado en 2020

The clinician's perspective on sarcoma pathology reporting: impact on treatment decisions?

artículo científico publicado en 2014

The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group

artículo científico publicado en 2018

The forefront of ovarian cancer therapy: update on PARP inhibitors

scientific article published on 19 June 2020

The histone deacetylase inhibitor panobinostat is active in patients with advanced pretreated ovarian sex-cord tumors

artículo científico publicado en 2014

The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy ⬇️

artículo científico publicado el 21 de agosto de 2012

The off-label use of targeted therapies in sarcomas: the OUTC'S program

artículo científico publicado en 2014

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma

artículo científico publicado en 2023

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value

artículo científico publicado en 2015

The value of research collaborations and consortia in rare cancers

artículo científico publicado en 2016

Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment

artículo científico publicado en 2020

Therapeutic pipeline for soft-tissue sarcoma

artículo científico publicado en 2011

Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group

artículo científico publicado en 2015

Trabectedin mechanism of action and platinum resistance: molecular rationale

artículo científico publicado en 2017

Transferability of health cost evaluation across locations in oncology: cluster and principal component analysis as an explorative tool

artículo científico publicado en 2014

Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study

scientific article published on 05 December 2018

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)

artículo científico publicado en 2017

Tumeur stromale colique asymptomatique révélée par un sarcome de Kaposi classique chez une malade VIH négative

artículo científico publicado en 2004

Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST.

artículo científico publicado en 2014

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

artículo científico publicado en 2011

Very long-term survivors among patients with metastatic soft tissue sarcoma

artículo científico publicado en 2019

[Adjuvant therapies: the example of breast cancer]

artículo científico publicado en 2008

[Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network]

artículo científico publicado en 2002

[Anemia and chemotherapy]

artículo científico publicado en 2003

[Angiogenesis and breast cancer]

artículo científico publicado en 2007

[Anticancer drugs management in renal insufficiency patients]

artículo científico publicado en 2012

[Antihormonal therapy in breast cancer and mTOR inhibitors]

artículo científico publicado en 2011

[Cancer: epidemiology, carcinogenesis, tumor evolution, classification]

scientific article published on 01 November 2004

[Care networks in oncology, an evidence for all?]

scientific article published on 01 July 2013

[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)]

artículo científico publicado en 2008

[Clinical practice guidelines: 2006 update of recommendations for the radiotherapeutic management of patients with soft tissue sarcoma (sarcoma of the extremity, uterine sarcoma and retroperitoneal sarcoma]

artículo científico publicado en 2006

[Current advances in immunotherapy in ovarian cancer]

artículo científico publicado en 2020

[Iron deficiency and anemia in oncology]

artículo científico publicado en 2012

[Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa]

artículo científico publicado en 2019

[Medical treatment in ovarian cancers newly diagnosed: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis

scientific article published on 29 January 2019

[Neoadjuvant chemotherapy and ovarian cancer]

artículo científico publicado en 2006

[Neoadjuvant chemotherapy in sarcoma]

artículo científico publicado en 2006

[Organization and impact of the multidisciplinary committee in oncology]

scientific article published on 01 October 2004

[Ovarian carcinogenesis: recent and past hypotheses]

artículo científico publicado en 2011

[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperat

scientific article published on 24 January 2019

[Part II drafted from the short text of the French guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment,

scientific article published on 28 January 2019

[Postoperative morbidities after modified posterior pelvic exenteration for ovarian cancer]

artículo científico publicado en 2015

[Prognostic factors for febrile neutropenia].

artículo científico publicado en 2006

[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France]

artículo científico publicado en 2010

[Renal insufficiency and breast cancer]

artículo científico publicado en 2012

[Standards & options: recommendations for the use of erythropoiesis-stimulating agents (ESA) in anaemic cancer patients undergoing radiotherapy (2007 update)]

scientific article published on 01 March 2008

[Surveillance Bulletin 2007. Guidelines for clinical practice: management of patients with malignant epithelial tumors of the ovary. First line medical treatment]

artículo científico publicado en 2007

[To answer rare cancer issues. Geographical analysis of EMS sarcoma cohort in the Rhône-Alpes region]

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda